Reimagining cardiac care with AliveCor’s first-of-its-kind KardiaMobile 6L: Reaffirming its commitment to transform cardiac care in the country, AliveCor – a global leader in compact artificial intelligence-based electrocardiogram (ECG) technology, successfully concluded a Continuing Medical Education (CME) program in Chandigarh.
As a part of the session, the company introduced the world’s only FDA-cleared six-lead compact ECG device – KardiaMobile 6L to the leading Cardiologists and physicians of the city. The event, chaired by Dr. Anurag Sharma, Director- Ojas Medical Services Pvt Ltd; Associate Director – Cardiology, Paras Hospital Panchkula, in presence of other senior cardiologists/physicians from top medical institutions of the region, discussed role of technologies and new health technology tools, including KardiaMoble 6L in delivering heart health to millions of people.
World’s only US-FDA cleared wireless ECG-reading device by AliveCor, KardiaMobile 6L, allows cardiac patients to self-record medical grade ECG in just about 30 seconds. The personal ECG device pairs with any Android or iPhone and can help identify various cardiac arrhythmias, commonly understood as irregular or disrupted heartbeat, to instantly detect if there’s any serious condition that needs medical intervention, allowing real-time remote monitoring by a Cardiologist. Cardiovascular diseases are one of the fastest growing non-communicable diseases, accounting for nearly half of all Non-communicable disease related deaths globally.
Speaking at the event, Dr Anurag Sharma, Director- Ojas Medical Services Pvt Ltd; Associate Director – Cardiology, Paras Hospital Panchkula, said, “With hundreds of millions at risk for heart disease across the globe, accessible heart care has never been more important. In the past one year, we have witnessed Covid acutely affecting patients with multiple underlying health conditions. At the same time, cases of heart ailments have increased over this time and we saw young people becoming susceptible to cardiovascular diseases. However, I feel, a lot of these cases can be managed better with timely intervention and monitoring at regular intervals. That’s where technologies/innovations like AliveCor’s KardiaMobile 6L will be useful in effectively drive patient-centric clinical excellence, as it allows people at-risk to do medical grade ECG/EKG anytime-anywhere”
Commenting on the development, Lokesh Prasad, Managing Director, AliveCor India, said, “On an average, heart disease affects people in India 8 to 10 years earlier compared to other parts of the world. This huge discrepancy can be explained by lack of exercise, improper diet and obesity, high prevalence of diabetes and genetic predisposition for premature heart disease. In addition, as the COVID pandemic continues to pose challenges in the way we interact in our everyday lives, we feel our new KardiaMobile 6L is a step in the right direction to transform cardiac care in the country through Artificial Intelligence basked remote ECG offering. With this, we aim to continuously innovate and bring about technologies to deliver best in class patient care in the country and markets beyond”
AliveCor, along with its scientific partners – Semper Centrum – continues to innovate to combat challenges in the cardiac care segment. Their unique patient-driven medical devices pave way improved patient safety and help fill up potential need gaps in India’s healthcare infrastructure. The devices are easy to use, accurate and precise.
